3.91
전일 마감가:
$3.8355
열려 있는:
$4.08
하루 거래량:
70,397
Relative Volume:
0.52
시가총액:
$12.25M
수익:
$36.12M
순이익/손실:
$-232.49M
주가수익비율:
-0.2199
EPS:
-17.78
순현금흐름:
$-126.87M
1주 성능:
-1.01%
1개월 성능:
-13.50%
6개월 성능:
-75.40%
1년 성능:
-93.18%
바이오나노 지노믹스 Stock (BNGO) Company Profile
명칭
Bionano Genomics Inc
전화
(858) 888-7600
주소
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
BNGO을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
BNGO
Bionano Genomics Inc
|
3.91 | 12.25M | 36.12M | -232.49M | -126.87M | -17.78 |
![]()
ISRG
Intuitive Surgical Inc
|
561.43 | 190.61B | 8.71B | 2.48B | 1.75B | 6.82 |
![]()
ALC
Alcon Inc
|
94.79 | 48.17B | 9.91B | 1.02B | 665.00M | 2.05 |
![]()
BDX
Becton Dickinson Co
|
175.34 | 47.86B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
RMD
Resmed Inc
|
247.66 | 35.29B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
COO
The Cooper Companies, Inc.
|
84.44 | 16.31B | 3.90B | 392.30M | 288.10M | 1.95 |
바이오나노 지노믹스 Stock (BNGO) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-11-15 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
2024-09-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
2023-01-05 | 개시 | Scotiabank | Sector Outperform |
2022-12-12 | 재개 | BTIG Research | Buy |
2022-07-18 | 재개 | Oppenheimer | Outperform |
2021-06-16 | 개시 | BTIG Research | Buy |
2020-09-24 | 개시 | Ladenburg Thalmann | Buy |
2020-04-08 | 개시 | Oppenheimer | Outperform |
모두보기
바이오나노 지노믹스 주식(BNGO)의 최신 뉴스
Bionano Genomics (BNGO) to Release Quarterly Earnings on Wednesday - Defense World
When (BNGO) Moves Investors should Listen - news.stocktradersdaily.com
Renaissance Technologies LLC Takes Position in Bionano Genomics, Inc. (NASDAQ:BNGO) - Defense World
Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025 - The Manila Times
Geode Capital Management LLC Acquires 114,822 Shares of Bionano Genomics, Inc. (NASDAQ:BNGO) - Defense World
Bionano Laboratories (BNGO) Gains Key Recommendations for Optical Genome Mapping | BNGO Stock News - GuruFocus
International Consortium for Optical Genome Mapping - GlobeNewswire
BioNano Genomics Executes Significant Reverse Stock Split - MSN
Where are the Opportunities in (BNGO) - news.stocktradersdaily.com
Bionano Genomics (BNGO) Highlights Optical Genome Mapping in Det - GuruFocus
Bionano Genomics (BNGO) Highlights Optical Genome Mapping in Detecting Genetic Disorders | BNGO Stock News - GuruFocus
Bionano Announces Publication Showing OGM can Provide an Accurate and Cost-Effective Solution for Sizing Large Repeat Expansions in Constitutional Genetic Disease - The Manila Times
Breakthrough Genetic Testing Study Reveals 98.8% Accuracy Rate for Bionano's Cost-Cutting Technology - Stock Titan
Bionano Reports Preliminary Fourth Quarter and Full-Year 2024 Results - ADVFN
Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025 - ADVFN
Brokers Set Expectations for BNGO Q1 Earnings - Defense World
Bionano Genomics (BNGO) Projects Stable Revenue Growth for 2025 - GuruFocus
Bionano Genomics (BNGO) Sees Revenue Upgrade Despite Lower Price Target - GuruFocus
Bionano Genomics (BNGO) Faces Revenue Growth, Missed EPS Targets - GuruFocus
Bionano Genomics (BNGO) Advances Multiple Myeloma Analysis - GuruFocus
Bionano Genomics (BNGO) Reports Q4 2024 Earnings: Revenue Decline but Margin Improvement - GuruFocus
Bionano Genomics (NASDAQ:BNGO) Coverage Initiated at HC Wainwright - Defense World
HC Wainwright & Co. Initiates Coverage of Bionano Genomics (BMV:BNGO) with Buy Recommendation - Nasdaq
HC Wainwright & Co. Initiates Coverage of Bionano Genomics (LSE:0A4K) with Buy Recommendation - Nasdaq
HC Wainwright & Co. Initiates Coverage of Bionano Genomics (BNGO) with Buy Recommendation - Nasdaq
HC Wainwright Initiates Bionano Genomics With Buy Rating, $10 Price Target - marketscreener.com
Richardson Electronics Q3 2025 Earnings Call Transcript - MarketBeat
Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM - The Manila Times
Breakthrough: French Study Reveals Game-Changing Multiple Myeloma Detection Method - Stock Titan
(BNGO) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Revenues Working Against Bionano Genomics, Inc.'s (NASDAQ:BNGO) Share Price Following 26% Dive - simplywall.st
Scotiabank Boosts Bionano Genomics (NASDAQ:BNGO) Price Target to $4.00 - Defense World
Bionano Genomics Inc Reports Q4 Revenue of $8.2 Million, Surpassing Estimates - GuruFocus
Analysts Are Upgrading Bionano Genomics, Inc. (NASDAQ:BNGO) After Its Latest Results - Yahoo Finance
Bionano Genomics Q4 Earnings Call: Mixed Sentiments and Strategic Shifts - TipRanks
Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2024 Earnings Call Transcript - Insider Monkey
Bionano Genomics Inc (BNGO) Q4 2024 Earnings Call Highlights: Strategic Cost Reductions and ... - Yahoo Finance
Bionano Genomics Inc (BNGO) Q4 2024 Earnings Call Highlights: Strategic Cost Reductions and ... By GuruFocus - Investing.com Canada
Bionano Genomics Reports 2024 Financial Results - TipRanks
Bionano Genomics outlines 2025 revenue guidance of $29M-$32M with strategic focus on utilization - MSN
Bionano Genomics (BNGO) Q4 2024 Earnings Call Transcript - Yahoo Finance
Bionano Genomics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Bionano Genomics Q4 2024 sees revenue drop By Investing.com - Investing.com South Africa
Earnings call transcript: Bionano Genomics Q4 2024 sees revenue drop - Investing.com
Bionano Genomics, Inc. SEC 10-K Report - TradingView
Bionano Genomics Reports Q4 and Full-Year 2024 Results - TradingView
Stock Market Correction: 2 Warren Buffett Stocks to Buy Hand Over Fist - The Globe and Mail
Bionano Genomics Inc expected to post a loss of $6.00 a shareEarnings Preview - TradingView
SoFi Stock Is Down 23% YTD. Should You Buy the Dip or Stay Away? - The Globe and Mail
What's Next: Bionano Genomics's Earnings Preview - Benzinga
Q4 Earnings Outperformers: Fastenal (NASDAQ:FAST) And The Rest Of The Maintenance and Repair Distributors Stocks - The Globe and Mail
바이오나노 지노믹스 (BNGO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):